Article Details

FDA Approves Dupilumab for Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

Retrieved on: 2025-04-18 18:15:08

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Dupilumab for Chronic Spontaneous Urticaria Uncontrolled by Antihistamines. View article details on hiswai:

Excerpt

Dupilumab is a monoclonal antibody that inhibits interleukin-4 (IL-4) ... antibodies, e.g., barzolvolimab; and anti-cytokine therapies, e.g. ...

Article found on: www.patientcareonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo